Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline add-on to interferon beta-1a in relapsing-remitting multiple sclerosis
2005-004289-18Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in multiple sclerosis (MS) comparing Minocycline add-on with Placebo add-on (2 arms). Primary endpoint: Time to first documented relapse. Started Nov 2005; status: terminated.
02
Drugs
minocycline
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2005-004289-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004289-18.